oral P2X3 ion channel antagonist

Ph. II, multiple settings (50-750 mg BID)

from literature P2X3 antagonists

Scientific Reports

Bayer AG, Berlin, DE

Chemical structure of molecule eliapixant (BAY1817080)

The Bayer P2X3 purinoreceptor antagonist, eliapixant (BAY1817080), is intended to treat various disorders associated with hypersensitive nerve fibers, including endometriosis. The hypothesis is that P2X3 receptor antagonism can inhibit cycles of…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: